Basic Information
RNALocate ID: RLID:01001991
RNA Symbol: hsa-miR-301a-3p
Localization: Cytoplasm
RNA Information
RNA Name: hsa-miR-301a
RNA ID: miRBase:MIMAT0000688
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21695135
Tissue/Cell Line: Cell line (HeLa)
Method: Microarray

Heatmap showing the 57 miRNAs differentially expressed in HeLa cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and reproducibly revealed 13 miRNAs enriched in mitochondrial RNA.

Originally published in PLoS One. Bandiera S, et al, 2011. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
Description: While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001992 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001993 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001994 Nucleus Colon adenocarcinoma cells 20864815
RLID:11002364 Exosome Serum 18589210
RLID:11002365 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002366 Exosome Renal cancer cells 21670082
RLID:11002367 Exosome Brain tissue 23382797
RLID:11002368 Exosome Plasma 23663360
RLID:11002369 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002370 Exosome Breast cancer cell lines (MCF-7|MDA-MB-231) 24468161
RLID:11002371 Extracellular vesicle Plasma 32498409
RLID-D:11000112 Exosome Endothelial cells|Mast cells
RLID-D:11000400 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-301a-3p Oral squamous cell carcinoma MNDR-E-MI-35721
MNDR hsa-miR-301a-3p Large cell neuroendocrine cancer MNDR-E-MI-35722
MNDR hsa-miR-301a-3p Follicular lymphoma MNDR-E-MI-35723
MNDR hsa-miR-301a-3p Small intestinal neuroendocrine tumor MNDR-E-MI-35724
MNDR hsa-miR-301a-3p High-grade serous ovarian carcinoma MNDR-E-MI-35725
MNDR hsa-miR-301a-3p Uterine corpus endometrial carcinoma MNDR-E-MI-35726
MNDR hsa-miR-301a-3p Lymphoma MNDR-E-MI-35727
MNDR hsa-miR-301a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-35728
MNDR hsa-miR-301a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-35729
MNDR hsa-miR-301a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-35730
MNDR hsa-miR-301a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-35731
MNDR hsa-miR-301a-3p Her2-receptor positive breast cancer MNDR-E-MI-35732
MNDR hsa-miR-301a-3p Breast cancer luminal MNDR-E-MI-35733
MNDR hsa-miR-301a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-35734
MNDR hsa-miR-301a-3p Small intestine cancer MNDR-E-MI-35735
MNDR hsa-miR-301a-3p Prostate cancer MNDR-E-MI-35736
MNDR hsa-miR-301a-3p Gastric cancer MNDR-E-MI-35737
MNDR hsa-miR-301a-3p Gastric lymphoma MNDR-E-MI-35738
MNDR hsa-miR-301a-3p Alzheimer disease MNDR-E-MI-35739
MNDR hsa-miR-301a-3p Intracranial aneurysm MNDR-E-MI-35740
MNDR hsa-miR-301a-3p Esophageal carcinoma MNDR-E-MI-35741
MNDR hsa-miR-301a-3p Dysautonomia familial MNDR-E-MI-35742
MNDR hsa-miR-301a-3p Seizures MNDR-E-MI-35743
MNDR hsa-miR-301a-3p Head and neck cancer MNDR-E-MI-35744
MNDR hsa-miR-301a-3p Vogt-koyanagi-harada disease MNDR-E-MI-35745
MNDR hsa-miR-301a-3p Leukemia MNDR-E-MI-35746
MNDR hsa-miR-301a-3p Cardiovascular disease MNDR-E-MI-35747
MNDR hsa-miR-301a-3p Lung cancer MNDR-E-MI-35748
MNDR hsa-miR-301a-3p Parkinson disease MNDR-E-MI-35749
MNDR hsa-miR-301a-3p Basal-like breast cancer MNDR-E-MI-35750
MNDR hsa-miR-301a-3p Thyroid cancer MNDR-E-MI-35751
MNDR hsa-miR-301a-3p Pancreatic cancer MNDR-E-MI-35752
MNDR hsa-miR-301a-3p Melanoma MNDR-E-MI-35753
MNDR hsa-miR-301a-3p Rectum adenocarcinoma MNDR-E-MI-35754
MNDR hsa-miR-301a-3p Nephroblastoma MNDR-E-MI-35755
MNDR hsa-miR-301a-3p Colon cancer MNDR-E-MI-35756
MNDR hsa-miR-301a-3p Colon adenocarcinoma MNDR-E-MI-35757
MNDR hsa-miR-301a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-35758
MNDR hsa-miR-301a-3p Familial ovarian cancer MNDR-E-MI-35759
MNDR hsa-miR-301a-3p Laryngeal squamous cell carcinoma MNDR-E-MI-35760
MNDR hsa-miR-301a-3p Carcinoma ductal breast MNDR-E-MI-35761
MNDR hsa-miR-301a-3p Glioblastoma MNDR-E-MI-35762
MNDR hsa-miR-301a-3p Glioma MNDR-E-MI-35763
MNDR hsa-miR-301a-3p Central nervous system lymphoma MNDR-E-MI-35764
MNDR hsa-miR-301a-3p Amyotrophic lateral sclerosis MNDR-E-MI-35765
MNDR hsa-miR-301a-3p Epilepsy temporal lobe MNDR-E-MI-35766
MNDR hsa-miR-301a-3p Osteosarcoma MNDR-E-MI-35767
MNDR hsa-miR-301a-3p Liposarcoma MNDR-E-MI-35768
MNDR hsa-miR-301a-3p Breast carcinoma MNDR-E-MI-35769
MNDR hsa-miR-301a-3p Uterine cancer MNDR-E-MI-35770
MNDR hsa-miR-301a-3p Gastric adenocarcinoma MNDR-E-MI-35771
MNDR hsa-miR-301a-3p Cervical squamous cell carcinoma MNDR-E-MI-35772
MNDR hsa-miR-301a-3p Lung squamous cell carcinoma MNDR-E-MI-35773
MNDR hsa-miR-301a-3p Non-small cell lung adenocarcinoma MNDR-E-MI-35774
MNDR hsa-miR-301a-3p Lung adenocarcinoma MNDR-E-MI-35775
MNDR hsa-miR-301a-3p Adrenocortical cancer MNDR-E-MI-35776
MNDR hsa-miR-301a-3p Ovarian carcinoma MNDR-E-MI-35777
MNDR hsa-miR-301a-3p Bladder urothelial carcinoma MNDR-E-MI-35778
MNDR hsa-miR-301a-3p Pancreatic adenocarcinoma MNDR-E-MI-35779
MNDR hsa-miR-301a-3p Carcinoma renal cell MNDR-E-MI-35780
MNDR hsa-miR-301a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-35781
MNDR hsa-miR-301a-3p Clear cell renal cell carcinoma MNDR-E-MI-35782
MNDR hsa-miR-301a-3p Cholangiocarcinoma MNDR-E-MI-35783
MNDR hsa-miR-301a-3p Esophageal cancer MNDR-E-MI-35784
MNDR hsa-miR-301a-3p Lung small cell carcinoma MNDR-E-MI-35785
MNDR hsa-miR-301a-3p Synovial sarcoma MNDR-E-MI-35786
MNDR hsa-miR-301a-3p Head and neck squamous cell carcinoma MNDR-E-MI-35787
MNDR hsa-miR-301a-3p Testicular germ cell cancer MNDR-E-MI-35788
MNDR hsa-miR-301a-3p Fibromyalgia MNDR-E-MI-35789
MNDR hsa-miR-301a-3p Pulmonary hypertension MNDR-E-MI-35790
MNDR hsa-miR-301a-3p Breast invasive carcinoma MNDR-E-MI-35791
MNDR hsa-miR-301a-3p Hepatocellular carcinoma MNDR-E-MI-35792
MNDR hsa-miR-301a-3p Familiar ovarian carcinoma MNDR-E-MI-35793
MNDR hsa-miR-301a-3p Rheumatoid arthritis MNDR-E-MI-35794
MNDR hsa-miR-301a-3p T-cell leukemia MNDR-E-MI-35795
MNDR hsa-miR-301a-3p Malignant pleural mesothelioma MNDR-E-MI-35796
MNDR hsa-miR-301a-3p Retinoblastoma MNDR-E-MI-35797
MNDR hsa-miR-301a-3p Hodgkin lymphoma MNDR-E-MI-35798
MNDR hsa-miR-301a-3p Tonsil cancer MNDR-E-MI-35799
MNDR hsa-miR-301a-3p Colorectal cancer MNDR-E-MI-35800
MNDR hsa-miR-301a-3p Nasopharynx carcinoma MNDR-E-MI-35801
MNDR hsa-miR-301a-3p Multiple myeloma MNDR-E-MI-35802
MNDR hsa-miR-301a-3p Acute lymphocytic leukemia MNDR-E-MI-35803
MNDR hsa-miR-301a-3p Ependymoma MNDR-E-MI-35804
MNDR hsa-miR-301a-3p Nasopharyngeal cancer MNDR-E-MI-35805
MNDR hsa-miR-301a-3p Prostatic neoplasms MNDR-E-MI-35806
MNDR hsa-miR-301a-3p Subarachnoid hemorrhage traumatic MNDR-E-MI-35807
MNDR hsa-miR-301a-3p Venous thromboembolism MNDR-E-MI-35808
MNDR hsa-miR-301a-3p Chronic pain MNDR-E-MI-35809
MNDR hsa-miR-301a-3p Stroke lacunar MNDR-E-MI-35810
MNDR hsa-miR-301a-3p Breast cancer her3+ negative MNDR-E-MI-35811
MNDR hsa-miR-301a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-35812
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ADCY3 Homo sapiens RR00044354
TOP